Impact of TAILORx on chemotherapy prescribing and 21‐gene recurrence score–guided treatment costs in a population‐based cohort of patients with breast cancer-Reference-Cited by-同舟云学术

Impact of TAILORx on chemotherapy prescribing and 21‐gene recurrence score–guided treatment costs in a population‐based cohort of patients with breast cancer

Published:2021-12-02 Issue:4 Volume:128 Page:665-674
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Tesch Megan E.¹^ORCID,Speers Caroline²,Diocee Rekha M.²,Gondara Lovedeep²,Peacock Stuart J.³^ORCID,Nichol Alan⁴^ORCID,Lohrisch Caroline A.¹

Affiliation:

1. Department of Medical Oncology BC Cancer Vancouver British Columbia Canada

2. Breast Cancer Outcomes Unit BC Cancer Vancouver British Columbia Canada

3. Canadian Centre for Applied Research in Cancer Control British Columbia Cancer Research Centre Vancouver British Columbia Canada

4. Department of Radiation Oncology BC Cancer Vancouver British Columbia Canada

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.33982

Reference24 articles.

1. A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer

2. Prediction of Risk of Distant Recurrence Using the 21-Gene Recurrence Score in Node-Negative and Node-Positive Postmenopausal Patients With Breast Cancer Treated With Anastrozole or Tamoxifen: A TransATAC Study

3. Reducing chemotherapy use in clinically high-risk, genomically low-risk pN0 and pN1 early breast cancer patients: five-year data from the prospective, randomised phase 3 West German Study Group (WSG) PlanB trial

4. Gene Expression and Benefit of Chemotherapy in Women With Node-Negative, Estrogen Receptor–Positive Breast Cancer

5. Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Trends in chemotherapy use for early-stage breast cancer from 2006 to 2019;Breast Cancer Research;2024-06-13

2. Direct and Indirect Costs of Breast Cancer and Associated Implications: A Systematic Review;Advances in Therapy;2024-06-04

3. Application of a 21-Gene Recurrence Score in a Swiss Single-Center Breast Cancer Population: A Comparative Analysis of Treatment Administration before and after TAILORx;Diagnostics;2023-12-31

4. Real-World Cost-Effectiveness Analysis: How Much Uncertainty Is in the Results?;Current Oncology;2023-04-07

5. Multi-gene assay 95- and 155-gene classifiers for prognosis prediction and chemotherapy omission in lymphnode positive luminal-type breast cancer;Cancer Treatment and Research Communications;2023